SNOA
NASDAQ · Pharmaceuticals
Sonoma Pharmaceuticals Inc
$1.11
+0.04 (+3.74%)
Open$1.10
Previous Close$1.07
Day High$1.15
Day Low$1.08
52W High$3.95
52W Low$0.85
Volume—
Avg Volume44.7K
Market Cap5.36M
P/E Ratio—
EPS$-1.22
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,064.9% upside
Current
$1.11
$1.11
Target
$12.93
$12.93
$7.21
$12.93 avg
$14.12
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 56.03M | 49.26M | 1.82M |
| Net Income | -9,109,430 | -7,207,461 | 463.1K |
| Profit Margin | -16.3% | -15.5% | 25.4% |
| EBITDA | -6,662,243 | -5,564,071 | 609.2K |
| Free Cash Flow | — | — | 381.4K |
| Rev Growth | +13.8% | +13.8% | -7.1% |
| Debt/Equity | 0.07 | 0.07 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |